Lv1
40 积分 2022-08-25 加入
Pan-immune inflammatory value a new diagnostic biomarker in postmenopausal osteoporosis
7个月前
已关闭
Icotinib versus gefitinib in previously treated advanced non-small-cell lung cancer (ICOGEN): a randomised, double-blind phase 3 non-inferiority trial
8个月前
已完结
Trial-Based Cost-Utility Analysis of Icotinib versus Gefitinib as Second-Line Therapy for Advanced Non-Small Cell Lung Cancer in China
8个月前
已完结
Clinical characteristics and overall survival of patients diagnosed with non-small cell lung cancer (NSCLC) between 2006 and 2017 in routine clinical practice: a retrospective analysis of a UK hospital database
8个月前
已完结
Artificial Intelligence in Oncology: Current Landscape, Challenges, and Future Directions
9个月前
已完结
[Chinese expert consensus on big data and real world study in cancer research (2022 edition)]
9个月前
已完结
Exploring Stage I non-small-cell lung cancer: development of a prognostic model predicting 5-year survival after surgical resection†
9个月前
已完结
Clinical characteristics and overall survival of patients diagnosed with non-small cell lung cancer (NSCLC) between 2006 and 2017 in routine clinical practice: a retrospective analysis of a UK hospital database
10个月前
已完结
Estimates and Projections of the Global Economic Cost of 29 Cancers in 204 Countries and Territories From 2020 to 2050
10个月前
已完结
Cancer incidence and mortality in China, 2022
10个月前
已完结
皖公网安备34019202002308
